LOIS M RAMONDETTA

TitleProfessor
InstitutionMD Anderson
DepartmentGynecological Oncology & Reproductive Medicine
Address1155 Pressler St
Houston TX 77030-3721
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Schmeler KM, Pareja R, Lopez Blanco A, Humberto Fregnani J, Lopes A, Perrotta M, Tsunoda AT, Cantú-de-León DF, Ramondetta LM, Manchana T, Crotzer DR, McNally OM, Riege M, Scambia G, Carvajal JM, Di Guilmi J, Rendon GJ, Ramalingam P, Fellman BM, Coleman RL, Frumovitz M, Ramirez PT. ConCerv: a prospective trial of conservative surgery for low-risk early-stage cervical cancer. Int J Gynecol Cancer. 2021 10; 31(10):1317-1325. PMID: 34493587.
      Citations: 1     Fields:    
    2. How JA, Patel S, Fellman B, Lu KH, Hwu P, Ramondetta LM, Westin SN, Fleming ND, Soliman PT, Jazaeri AA. Toxicity and efficacy of the combination of pembrolizumab with recommended or reduced starting doses of lenvatinib for treatment of recurrent endometrial cancer. Gynecol Oncol. 2021 07; 162(1):24-31. PMID: 33958211.
      Citations: 1     Fields:    
    3. El Alam MB, Sims TT, Kouzy R, Biegert GWG, Jaoude JABI, Karpinets TV, Yoshida-Court K, Wu X, Delgado-Medrano AY, Mezzari MP, Ajami NJ, Solley T, Ahmed-Kaddar M, Lin LL, Ramondetta L, Jazaeri A, Jhingran A, Eifel PJ, Schmeler KM, Wargo J, Klopp AH, Colbert LE. A prospective study of the adaptive changes in the gut microbiome during standard-of-care chemoradiotherapy for gynecologic cancers. PLoS One. 2021; 16(3):e0247905. PMID: 33662003.
      Citations: 2     Fields:    Translation:HumansCells
    4. Sims TT, El Alam MB, Karpinets TV, Dorta-Estremera S, Hegde VL, Nookala S, Yoshida-Court K, Wu X, Biegert GWG, Delgado Medrano AY, Solley T, Ahmed-Kaddar M, Chapman BV, Sastry KJ, Mezzari MP, Petrosino JF, Lin LL, Ramondetta L, Jhingran A, Schmeler KM, Ajami NJ, Wargo J, Colbert LE, Klopp AH. Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation. Commun Biol. 2021 02 22; 4(1):237. PMID: 33619320.
      Citations: 7     Translation:HumansCells
    5. Tewari KS, Sill MW, Monk BJ, Penson RT, Moore DH, Lankes HA, Ramondetta LM, Landrum LM, Randall LM, Oaknin A, Leitao MM, Eisenhauer EL, DiSilvestro P, Van Le L, Pearl ML, Burke JJ, Salani R, Richardson DL, Michael HE, Kindelberger DW, Birrer MJ. Circulating Tumor Cells In Advanced Cervical Cancer: NRG Oncology-Gynecologic Oncology Group Study 240 (NCT 00803062). Mol Cancer Ther. 2020 11; 19(11):2363-2370. PMID: 32847980.
      Citations: 3     Fields:    
    6. Cho D, Ramondetta L, Garcini L, Lu Q. HPVs Vaccination among Racial/Ethnic Minority College Students: Current Status and Future Direction. J Natl Med Assoc. 2020 Dec; 112(6):639-649. PMID: 32665067.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    7. Li Y, Yang S, Sadaoui NC, Hu W, Dasari SK, Mangala LS, Sun Y, Zhao S, Wang L, Liu Y, Ramondetta LM, Li K, Lu C, Kang Y, Cole SW, Lutgendorf SK, Sood AK. Sustained Adrenergic Activation of YAP1 Induces Anoikis Resistance in Cervical Cancer Cells. iScience. 2020 Jul 24; 23(7):101289. PMID: 32623336.
      Citations: 2     
    8. Chase D, Huang HQ, Monk BJ, Ramondetta LM, Penson RT, Gil K, Landrum LM, Leitao M, Oaknin A, Huh WK, Pulaski HL, Robison K, Guntupalli SR, Richardson D, Salani R, Sill MW, Wenzel LB, Tewari KS. Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study. Int J Gynecol Cancer. 2020 05; 30(5):596-601. PMID: 32114513.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    9. Mitra A, Grossman Biegert GW, Delgado AY, Karpinets TV, Solley TN, Mezzari MP, Yoshida-Court K, Petrosino JF, Mikkelson MD, Lin L, Eifel P, Zhang J, Ramondetta LM, Jhingran A, Sims TT, Schmeler K, Okhuysen P, Colbert LE, Klopp AH. Microbial Diversity and Composition Is Associated with Patient-Reported Toxicity during Chemoradiation Therapy for Cervical Cancer. Int J Radiat Oncol Biol Phys. 2020 05 01; 107(1):163-171. PMID: 31987960.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    10. Sims TT, Colbert LE, Zheng J, Delgado Medrano AY, Hoffman KL, Ramondetta L, Jazaeri A, Jhingran A, Schmeler KM, Daniel CR, Klopp A. Gut microbial diversity and genus-level differences identified in cervical cancer patients versus healthy controls. Gynecol Oncol. 2019 11; 155(2):237-244. PMID: 31500892.
      Citations: 11     Fields:    Translation:Humans
    11. Shelal Z, Cho D, Urbauer DL, Lu Q, Ma BY, Rohrer AM, Kurian S, Sturgis EM, Ramondetta LM. Knowledge matters and empowers: HPV vaccine advocacy among HPV-related cancer survivors. Support Care Cancer. 2020 May; 28(5):2407-2413. PMID: 31489512.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    12. Ramondetta LM, Hu W, Thaker PH, Urbauer DL, Chisholm GB, Westin SN, Sun Y, Ramirez PT, Fleming N, Sahai SK, Nick AM, Arevalo JMG, Dizon T, Coleman RL, Cole SW, Sood AK. Prospective pilot trial with combination of propranolol with chemotherapy in patients with epithelial ovarian cancer and evaluation on circulating immune cell gene expression. Gynecol Oncol. 2019 09; 154(3):524-530. PMID: 31353053.
      Citations: 6     Fields:    Translation:HumansCellsCTClinical Trials
    13. Parkes A, Nusrat M, Di Tomasso PM, Davis L, Ogbonnaya S, Iwuorie M, Patel S, Abraham TG, Mack R, Bhadkamkar NA, Ma H, Nazario LA, Ramondetta L, Rosenstock A, Rieber AG. Successful Implementation of a Multidisciplinary Chemotherapy Efficiency Initiative at a Community Hospital. J Oncol Pract. 2019 06; 15(6):e576-e582. PMID: 30990730.
      Citations:    Fields:    Translation:Humans
    14. Liu W, Qdaisat A, Soliman PT, Ramondetta L, Lopez G, Narayanan S, Zhou S, Cohen L, Bruera E, Yeung SJ. Hypomagnesemia and Survival in Patients with Ovarian Cancer Who Received Chemotherapy with Carboplatin. Oncologist. 2019 06; 24(6):e312-e317. PMID: 30940743.
      Citations: 3     Fields:    Translation:Humans
    15. Fu S, Fokom Domgue J, Chan W, Zhao B, Ramondetta LM, Lairson DR. Cervical, Vaginal, and Vulvar Cancer Costs Incurred by the Medicaid Program in Publicly Insured Patients in Texas. J Low Genit Tract Dis. 2019 Apr; 23(2):102-109. PMID: 30907776.
      Citations:    Fields:    Translation:Humans
    16. Wiley R, Shelal Z, Bernard C, Urbauer D, Toy E, Ramondetta L. Team-Based Learning Module for Undergraduate Medical Education: a Module Focused on the Human Papilloma Virus to Increase Willingness to Vaccinate. J Cancer Educ. 2019 04; 34(2):357-362. PMID: 29280059.
      Citations: 2     Fields:    Translation:Humans
    17. Taylor JS, Zhang N, Rajan SS, Chavez-MacGregor M, Zhao H, Niu J, Meyer LA, Ramondetta LM, Bodurka DC, Lairson DR, Giordano SH. How we use hospice: Hospice enrollment patterns and costs in elderly ovarian cancer patients. Gynecol Oncol. 2019 03; 152(3):452-458. PMID: 30876488.
      Citations: 1     Fields:    Translation:Humans
    18. Wiley R, Shelal Z, Urbauer D, Bernard C, Ramondetta L. Relationship Between Intent to Vaccinate and the Education and Knowledge of Human Papillomavirus Among Medical School Faculty and Students in Texas. Tex Med. 2019 Jan 01; 115(1):e1. PMID: 30601572.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    19. Wiley R, Shelal Z, Bernard C, Urbauer D, Toy E, Ramondetta L. Human Papillomavirus: From Basic Science to Clinical Management for Preclinical Medical Students. MedEdPORTAL. 2018 12 21; 14:10787. PMID: 30800987.
      Citations: 3     Fields:    Translation:HumansCells
    20. Bednar EM, Sun CC, Camacho B, Terrell J, Rieber AG, Ramondetta LM, Freedman RS, Lu KH. Disseminating universal genetic testing to a diverse, indigent patient population at a county hospital gynecologic oncology clinic. Gynecol Oncol. 2019 02; 152(2):328-333. PMID: 30528888.
      Citations: 2     Fields:    Translation:Humans
    21. Kurnit KC, Previs RA, Soliman PT, Westin SN, Klopp AH, Fellman BM, Lu KH, Ramondetta LM, Fleming ND. Prognostic factors impacting survival in early stage uterine carcinosarcoma. Gynecol Oncol. 2019 01; 152(1):31-37. PMID: 30414738.
      Citations: 5     Fields:    Translation:Humans
    22. Dahlstrom KR, Fu S, Chan W, Shelal Z, Ramondetta LM, Lairson DR. Medical Care Costs Associated with Genital Warts for Commercially Insured US Patients. Pharmacoeconomics. 2018 11; 36(11):1355-1365. PMID: 30019118.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    23. Peng HL, Tam S, Xu L, Dahlstrom KR, Wu CF, Fu S, Zhong C, Chan W, Sturgis EM, Ramondetta L, Rong L, Lairson DR, Miao H. Age-Structured Population Modeling of HPV-related Cervical Cancer in Texas and US. Sci Rep. 2018 09 25; 8(1):14346. PMID: 30254252.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    24. Armbruster SD, Sun CC, Westin SN, Bodurka DC, Ramondetta L, Meyer LA, Soliman PT. Prospective assessment of patient-reported outcomes in gynecologic cancer patients before and after pelvic exenteration. Gynecol Oncol. 2018 06; 149(3):484-490. PMID: 29622276.
      Citations: 1     Fields:    Translation:Humans
    25. Hwang JP, Ahmed S, Ariza-Heredia EJ, Duan Z, Zhao H, Schmeler KM, Ramondetta L, Parker SL, Suarez-Almazor ME, Ferrajoli A, Shih YT, Giordano SH, Chiao EY. Low Rate of Cervical Cancer Screening among Women with Hematologic Malignancies after Stem Cell Transplant. Biol Blood Marrow Transplant. 2018 05; 24(5):1094-1098. PMID: 29378304.
      Citations: 1     Fields:    Translation:Humans
    26. Prinsloo S, Novy D, Driver L, Lyle R, Ramondetta L, Eng C, Lopez G, Li Y, Cohen L. The Long-Term Impact of Neurofeedback on Symptom Burden and Interference in Patients With Chronic Chemotherapy-Induced Neuropathy: Analysis of a Randomized Controlled Trial. J Pain Symptom Manage. 2018 05; 55(5):1276-1285. PMID: 29421164.
      Citations: 6     Fields:    Translation:Humans
    27. Pal N, Broaddus RR, Urbauer DL, Balakrishnan N, Milbourne A, Schmeler KM, Meyer LA, Soliman PT, Lu KH, Ramirez PT, Ramondetta L, Bodurka DC, Westin SN. Treatment of Low-Risk Endometrial Cancer and Complex Atypical Hyperplasia With the Levonorgestrel-Releasing Intrauterine Device. Obstet Gynecol. 2018 01; 131(1):109-116. PMID: 29215513.
      Citations: 34     Fields:    Translation:Humans
    28. Gunther JR, Christensen EN, Allen PK, Ramondetta LM, Jhingran A, Fleming ND, Euscher ED, Lu KH, Eifel PJ, Klopp AH. Role of Radiation Therapy in the Multidisciplinary Management of Uterine Carcinosarcoma. Int J Gynecol Cancer. 2018 01; 28(1):114-121. PMID: 28930812.
      Citations: 1     Fields:    Translation:Humans
    29. Fu S, Lairson DR, Chan W, Wu CF, Ramondetta L. Mean medical costs associated with vaginal and vulvar cancers for commercially insured patients in the United States and Texas. Gynecol Oncol. 2018 02; 148(2):342-348. PMID: 29274828.
      Citations: 3     Fields:    Translation:Humans
    30. Ramondetta L. Response to Harper and De Mars, HPV vaccines: A review of the first decade. Gynecol Oncol Rep. 2017 Nov; 22:113-114. PMID: 29296654.
      Citations: 1     
    31. Suidan RS, He W, Sun CC, Zhao H, Ramondetta LM, Badgwell BD, Bodurka DC, Lu KH, Giordano SH, Meyer LA. Treatment Patterns, Outcomes, and Costs for Bowel Obstruction in Ovarian Cancer. Int J Gynecol Cancer. 2017 09; 27(7):1350-1359. PMID: 28574929.
      Citations: 1     Fields:    Translation:Humans
    32. Essel KG, Bruegl A, Gershenson DM, Ramondetta LM, Naumann RW, Brown J. Salvage chemotherapy for gestational trophoblastic neoplasia: Utility or futility? Gynecol Oncol. 2017 07; 146(1):74-80. PMID: 28473205.
      Citations: 2     Fields:    Translation:Humans
    33. Brown AJ, Shen MJ, Urbauer D, Taylor J, Parker PA, Carmack C, Prescott L, Rosemore C, Kolawole E, Sun C, Ramondetta L, Bodurka DC. The Advance Care Planning Readiness Scale: Development and Validation of a Measure of Willingness to Discuss and Acceptance of End-of-Life Care in Gynecologic Cancer Patients. Int J Gynecol Cancer. 2017 05; 27(4):838-846. PMID: 28399031.
      Citations: 3     Fields:    Translation:Humans
    34. Prinsloo S, Novy D, Driver L, Lyle R, Ramondetta L, Eng C, McQuade J, Lopez G, Cohen L. Randomized controlled trial of neurofeedback on chemotherapy-induced peripheral neuropathy: A pilot study. Cancer. 2017 06 01; 123(11):1989-1997. PMID: 28257146.
      Citations: 5     Fields:    Translation:Humans
    35. Lairson DR, Fu S, Chan W, Xu L, Shelal Z, Ramondetta L. Mean direct medical care costs associated with cervical cancer for commercially insured patients in Texas. Gynecol Oncol. 2017 04; 145(1):108-113. PMID: 28196673.
      Citations: 3     Fields:    Translation:Humans
    36. Brown AJ, Thaker PH, Sun CC, Urbauer DL, Bruera E, Bodurka DC, Ramondetta LM. Nothing left to chance? The impact of locus of control on physical and mental quality of life in terminal cancer patients. Support Care Cancer. 2017 06; 25(6):1985-1991. PMID: 28175997.
      Citations: 2     Fields:    Translation:Humans
    37. Javaid M, Ashrawi D, Landgren R, Stevens L, Bello R, Foxhall L, Mims M, Ramondetta L. Human Papillomavirus Vaccine Uptake in Texas Pediatric Care Settings: A Statewide Survey of Healthcare Professionals. J Community Health. 2017 Feb; 42(1):58-65. PMID: 27473752.
      Citations: 9     Fields:    Translation:Humans
    38. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 25638326.
      Citations: 42     Fields:    Translation:HumansCTClinical Trials
    39. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 27439968.
      Citations: 3     Fields:    Translation:Humans
    40. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 30157165.
      Citations:    Fields:    Translation:Humans
    41. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 29680231.
      Citations: 4     Fields:    Translation:Humans
    42. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 20665499.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    43. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 12825629.
      Citations: 6     Fields:    Translation:Humans
    44. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 24905618.
      Citations: 2     Fields:    Translation:Humans
    45. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 15992917.
      Citations: 1     Fields:    Translation:Humans
    46. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 25014540.
      Citations: 15     Fields:    Translation:Humans
    47. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 10656459.
      Citations: 6     Fields:    Translation:HumansCells
    48. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 11585425.
      Citations: 2     Fields:    Translation:Humans
    49. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 15894930.
      Citations: 4     Fields:    Translation:Humans
    50. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 12060455.
      Citations: 6     Fields:    Translation:HumansCells
    51. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 14967435.
      Citations: 44     Fields:    Translation:HumansPHPublic Health
    52. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 13678720.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    53. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 14675663.
      Citations: 57     Fields:    Translation:Humans
    54. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 15086714.
      Citations: 3     Fields:    Translation:Humans
    55. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 15863149.
      Citations: 23     Fields:    Translation:Humans
    56. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 15882178.
      Citations: 3     Fields:    Translation:Humans
    57. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 9891537.
      Citations:    Fields:    Translation:HumansCells
    58. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 18753181.
      Citations: 4     Fields:    Translation:HumansCells
    59. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 19632709.
      Citations: 30     Fields:    Translation:Humans
    60. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 21436706.
      Citations: 7     Fields:    Translation:Humans
    61. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 28756902.
      Citations: 93     Fields:    Translation:HumansCTClinical Trials
    62. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 28388292.
      Citations: 11     Fields:    Translation:Humans
    63. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 31725471.
      Citations: 11     Fields:    Translation:Humans
    64. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 32338316.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    65. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 32805208.
      Citations: 9     Fields:    Translation:HumansCellsCTClinical Trials
    66. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 33392125.
      Citations:    Translation:HumansPHPublic Health
    67. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 33415580.
      Citations: 1     Fields:    
    68. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 33469199.
      Citations:    Fields:    Translation:HumansCells
    69. Wang Z, Shi N, Naing A, Janku F, Subbiah V, Araujo DM, Patel SR, Ludwig JA, Ramondetta LM, Levenback CF, Ramirez PT, Piha-Paul SA, Hong D, Karp DD, Tsimberidou AM, Meric-Bernstam F, Fu S. Survival of patients with metastatic leiomyosarcoma: the MD Anderson Clinical Center for targeted therapy experience. Cancer Med. 2016 12; 5(12):3437-3444. PMID: 27882721.
      Citations: 9     Fields:    Translation:Humans
    70. Soliman PT, Zhang Q, Broaddus RR, Westin SN, Iglesias D, Munsell MF, Schmandt R, Yates M, Ramondetta L, Lu KH. Prospective evaluation of the molecular effects of metformin on the endometrium in women with newly diagnosed endometrial cancer: A window of opportunity study. Gynecol Oncol. 2016 Dec; 143(3):466-471. PMID: 27745917.
      Citations: 17     Fields:    Translation:Humans
    71. Bui TC, Thai TN, Tran LT, Shete SS, Ramondetta LM, Basen-Engquist KM. Association Between Vaginal Douching and Genital Human Papillomavirus Infection Among Women in the United States. J Infect Dis. 2016 Nov 01; 214(9):1370-1375. PMID: 27553042.
      Citations: 4     Fields:    Translation:HumansCells
    72. Taylor JS, Brown AJ, Prescott LS, Sun CC, Ramondetta LM, Bodurka DC. Dying well: How equal is end of life care among gynecologic oncology patients? Gynecol Oncol. 2016 Feb; 140(2):295-300. PMID: 26706661.
      Citations: 8     Fields:    Translation:Humans
    73. Fu S, Shi N, Wheler J, Naing A, Janku F, Piha-Paul S, Gong J, Hong D, Tsimberidou A, Zinner R, Subbiah V, Hou MM, Ramirez P, Ramondetta L, Lu K, Meric-Bernstam F. Characteristics and outcomes for patients with advanced vaginal or vulvar cancer referred to a phase I clinical trials program: the MD Anderson cancer center experience. Gynecol Oncol Res Pract. 2015; 2:10. PMID: 27231570.
      Citations: 4     
    74. Ramondetta LM, Meyer LA, Schmeler KM, Daheri ME, Gallegos J, Scheurer M, Montealegre JR, Milbourne A, Anderson ML, Sun CC. Avoidable tragedies: Disparities in healthcare access among medically underserved women diagnosed with cervical cancer. Gynecol Oncol. 2015 Dec; 139(3):500-5. PMID: 26498912.
      Citations: 11     Fields:    Translation:Humans
    75. Kim YJ, Munsell MF, Park JC, Meyer LA, Sun CC, Brown AJ, Bodurka DC, Williams JL, Chase DM, Bruera E, Ramondetta LM. Retrospective review of symptoms and palliative care interventions in women with advanced cervical cancer. Gynecol Oncol. 2015 Dec; 139(3):553-8. PMID: 26432043.
      Citations: 9     Fields:    Translation:Humans
    76. Bradford A, Fellman B, Urbauer D, Gallegos J, Meaders K, Tung C, Ramondetta L. Assessment of sexual activity and dysfunction in medically underserved women with gynecologic cancers. Gynecol Oncol. 2015 Oct; 139(1):134-40. PMID: 26325527.
      Citations: 4     Fields:    Translation:Humans
    77. Watkins JL, Thaker PH, Nick AM, Ramondetta LM, Kumar S, Urbauer DL, Matsuo K, Squires KC, Coleman RL, Lutgendorf SK, Ramirez PT, Sood AK. Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancer. Cancer. 2015 Oct 01; 121(19):3444-51. PMID: 26301456.
      Citations: 75     Fields:    Translation:Humans
    78. Montealegre JR, Landgren RM, Anderson ML, Hoxhaj S, Williams S, Robinson DJ, Scheurer ME, Ramondetta LM. Acceptability of self-sample human papillomavirus testing among medically underserved women visiting the emergency department. Gynecol Oncol. 2015 Aug; 138(2):317-22. PMID: 26026733.
      Citations: 6     Fields:    Translation:HumansCells
    79. Brown AJ, Sun CC, Urbauer DL, Bodurka DC, Thaker PH, Ramondetta LM. Feeling powerless: Locus of control as a potential target for supportive care interventions to increase quality of life and decrease anxiety in ovarian cancer patients. Gynecol Oncol. 2015 Aug; 138(2):388-93. PMID: 25988961.
      Citations: 7     Fields:    Translation:Humans
    80. Chase DM, Kauderer J, Wenzel L, Ramondetta L, Cella D, Long HJ, Monk BJ. Factors associated with grade 3 or 4 treatment-related toxicity in women with advanced or recurrent cervical cancer: an exploratory analysis of NRG Oncology/Gynecologic Oncology Group trials 179 and 204. Int J Gynecol Cancer. 2015 Feb; 25(2):303-8. PMID: 25405577.
      Citations: 1     Fields:    Translation:Humans
    81. Brown AJ, Sun CC, Urbauer D, Zhukovsky DS, Levenback C, Frumovitz M, Thaker PH, Bodurka DC, Ramondetta LM. Targeting those with decreased meaning and peace: a supportive care opportunity. Support Care Cancer. 2015 Jul; 23(7):2025-32. PMID: 25519758.
      Citations: 3     Fields:    Translation:Humans
    82. Rycaj K, Plummer JB, Yin B, Li M, Garza J, Radvanyi L, Ramondetta LM, Lin K, Johanning GL, Tang DG, Wang-Johanning F. Cytotoxicity of human endogenous retrovirus K-specific T cells toward autologous ovarian cancer cells. Clin Cancer Res. 2015 Jan 15; 21(2):471-83. PMID: 25370465.
      Citations: 28     Fields:    Translation:HumansCells
    83. Brown AJ, Shen MJ, Ramondetta LM, Bodurka DC, Giuntoli RL, Diaz-Montes T. Does death anxiety affect end-of-life care discussions? Int J Gynecol Cancer. 2014 Oct; 24(8):1521-6. PMID: 25188890.
      Citations: 4     Fields:    Translation:Humans
    84. Brown AJ, Sun CC, Prescott LS, Taylor JS, Ramondetta LM, Bodurka DC. Missed opportunities: Patterns of medical care and hospice utilization among ovarian cancer patients. Gynecol Oncol. 2014 Nov; 135(2):244-8. PMID: 25192878.
      Citations: 9     Fields:    Translation:Humans
    85. Miller DS, Blessing JA, Ramondetta LM, Pham HQ, Tewari KS, Landrum LM, Brown J, Mannel RS. Pemetrexed and cisplatin for the treatment of advanced, persistent, or recurrent carcinoma of the cervix: a limited access phase II trial of the gynecologic oncology group. J Clin Oncol. 2014 Sep 01; 32(25):2744-9. PMID: 25071133.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    86. Tewari KS, Sill MW, Long HJ, Penson RT, Huang H, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao MM, Michael HE, Monk BJ. Improved survival with bevacizumab in advanced cervical cancer. N Engl J Med. 2014 Feb 20; 370(8):734-43. PMID: 24552320.
      Citations: 368     Fields:    Translation:HumansCTClinical Trials
    87. Zaid T, Burzawa J, Basen-Engquist K, Bodurka DC, Ramondetta LM, Brown J, Frumovitz M. Use of social media to conduct a cross-sectional epidemiologic and quality of life survey of patients with neuroendocrine carcinoma of the cervix: a feasibility study. Gynecol Oncol. 2014 Jan; 132(1):149-53. PMID: 24145111.
      Citations: 17     Fields:    Translation:Humans
    88. Nagaraja AS, Sadaoui NC, Lutgendorf SK, Ramondetta LM, Sood AK. ß-blockers: a new role in cancer chemotherapy? Expert Opin Investig Drugs. 2013 Nov; 22(11):1359-63. PMID: 23919278.
      Citations: 11     Fields:    Translation:Humans
    89. Ramondetta LM, Sun C, Surbone A, Olver I, Ripamonti C, Konishi T, Baider L, Johnson J. Surprising results regarding MASCC members' beliefs about spiritual care. Support Care Cancer. 2013 Nov; 21(11):2991-8. PMID: 23775154.
      Citations: 7     Fields:    Translation:Humans
    90. Sailors MH, Bodurka DC, Gning I, Ramondetta LM, Williams LA, Mendoza TR, Agarwal S, Sun CC, Cleeland CS. Validating the M. D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian cancer. Gynecol Oncol. 2013 Aug; 130(2):323-8. PMID: 23685012.
      Citations: 14     Fields:    Translation:Humans
    91. Costales AB, Milbourne AM, Rhodes HE, Munsell MF, Wallbillich JJ, Brown J, Frumovitz M, Ramondetta LM, Schmeler KM. Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix. Gynecol Oncol. 2013 Jun; 129(3):513-6. PMID: 23541795.
      Citations: 4     Fields:    Translation:Humans
    92. Ramondetta L. What is the appropriate approach to treating women with incurable cervical cancer? J Natl Compr Canc Netw. 2013 Mar 01; 11(3):348-55. PMID: 23486459.
      Citations: 8     Fields:    Translation:Humans
    93. Jhingran A, Ramondetta LM, Bodurka DC, Slomovitz BM, Brown J, Levy LB, Garcia ME, Eifel PJ, Lu KH, Burke TW. A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I-IIIA (1988) uterine papillary serous carcinoma of the endometrium. Gynecol Oncol. 2013 May; 129(2):304-9. PMID: 23385150.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    94. Thaker PH, Sood AK, Ramondetta LM. Importance of adrenergic pathways in women's cancers. Cancer Biomark. 2013; 13(3):145-54. PMID: 23912486.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    95. Alberts DS, Blessing JA, Landrum LM, Warshal DP, Martin LP, Rose SL, Bonebrake AJ, Ramondetta LM. Phase II trial of nab-paclitaxel in the treatment of recurrent or persistent advanced cervix cancer: A gynecologic oncology group study. Gynecol Oncol. 2012 Dec; 127(3):451-5. PMID: 22986144.
      Citations: 14     Fields:    Translation:HumansCTClinical Trials
    96. Frumovitz M, Ramirez PT, Macapinlac HA, Klopp AH, Nick AM, Ramondetta LM, Jhingran A. Anatomic location of PET-positive aortocaval nodes in patients with locally advanced cervical cancer: implications for surgical staging. Int J Gynecol Cancer. 2012 Sep; 22(7):1203-7. PMID: 22810967.
      Citations: 4     Fields:    Translation:Humans
    97. Ramondetta L, Zaid TM, Wallace AM. "Doctor, what did I do to deserve this?". Palliat Support Care. 2011 Dec; 9(4):425-7. PMID: 22104419.
      Citations:    Fields:    Translation:Humans
    98. Ramondetta LM, Urbauer D, Brown AJ, Richardson G, Thaker PH, Koenig HG, Levenback C, Sun C. Work related stress among gynecologic oncologists. Gynecol Oncol. 2011 Nov; 123(2):365-9. PMID: 21777966.
      Citations: 2     Fields:    Translation:Humans
    99. Seth SG, Goka T, Harbison A, Hollier L, Peterson S, Ramondetta L, Noblin SJ. Exploring the role of religiosity and spirituality in amniocentesis decision-making among Latinas. J Genet Couns. 2011 Dec; 20(6):660-73. PMID: 21695589.
      Citations: 10     Fields:    Translation:Humans
    100. Lacour RA, Euscher E, Atkinson EN, Sun CC, Ramirez PT, Coleman RL, Brown J, Gano JB, Burke TW, Ramondetta LM. A phase II trial of paclitaxel and carboplatin in women with advanced or recurrent uterine carcinosarcoma. Int J Gynecol Cancer. 2011 Apr; 21(3):517-22. PMID: 21436700.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    101. Schlumbrecht MP, Gallagher CM, Sun CC, Ramondetta LM, Bodurka DC. Ethics consultation on a gynecologic oncology service: an opportunity for physician education. J Cancer Educ. 2011 Mar; 26(1):183-7. PMID: 20835927.
      Citations:    Fields:    Translation:Humans
    102. Julius JM, Ramondeta L, Tipton KA, Lal LS, Schneider K, Smith JA. Clinical perspectives on the role of the human papillomavirus vaccine in the prevention of cancer. Pharmacotherapy. 2011 Mar; 31(3):280-97. PMID: 21361739.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    103. Burzawa JK, Schmeler KM, Soliman PT, Meyer LA, Bevers MW, Pustilnik TL, Anderson ML, Ramondetta LM, Tortolero-Luna G, Urbauer DL, Chang S, Gershenson DM, Brown J, Lu KH. Prospective evaluation of insulin resistance among endometrial cancer patients. Am J Obstet Gynecol. 2011 Apr; 204(4):355.e1-7. PMID: 21324431.
      Citations: 13     Fields:    Translation:Humans
    104. Kincey J, Westin SN, Zhao B, Curtis MG, Ramondetta L. Surgical removal of a gigantic abdominal mass: a multidisciplinary approach. Obstet Gynecol. 2011 Feb; 117(2 Pt 2):508-512. PMID: 21252807.
      Citations: 2     Fields:    Translation:Humans
    105. Shen Q, Stanton ML, Feng W, Rodriguez ME, Ramondetta L, Chen L, Brown RE, Duan X. Morphoproteomic analysis reveals an overexpressed and constitutively activated phospholipase D1-mTORC2 pathway in endometrial carcinoma. Int J Clin Exp Pathol. 2010 Nov 20; 4(1):13-21. PMID: 21228924.
      Citations: 19     Fields:    Translation:HumansCells
    106. Ramirez PT, Jhingran A, Macapinlac HA, Euscher ED, Munsell MF, Coleman RL, Soliman PT, Schmeler KM, Frumovitz M, Ramondetta LM. Laparoscopic extraperitoneal para-aortic lymphadenectomy in locally advanced cervical cancer: a prospective correlation of surgical findings with positron emission tomography/computed tomography findings. Cancer. 2011 May 01; 117(9):1928-34. PMID: 21509770.
      Citations: 32     Fields:    Translation:HumansCTClinical Trials
    107. Clements A, Euscher E, Lacour R, Merritt W, Klopp A, Ramondetta L. The presence of human papillomavirus or p16 in six cases of retroperitoneal carcinoma. Obstet Gynecol. 2010 Nov; 116(5):1042-6. PMID: 20966687.
      Citations: 4     Fields:    Translation:HumansCells
    108. Palos GR, Mendoza TR, Liao KP, Anderson KO, Garcia-Gonzalez A, Hahn K, Nazario A, Ramondetta LM, Valero V, Lynch GR, Jibaja-Weiss ML, Cleeland CS. Caregiver symptom burden: the risk of caring for an underserved patient with advanced cancer. Cancer. 2011 Mar 01; 117(5):1070-9. PMID: 20960510.
      Citations: 38     Fields:    Translation:Humans
    109. Cella D, Huang HQ, Monk BJ, Wenzel L, Benda J, McMeekin DS, Cohn D, Ramondetta L, Boardman CH. Health-related quality of life outcomes associated with four cisplatin-based doublet chemotherapy regimens for stage IVB recurrent or persistent cervical cancer: a Gynecologic Oncology Group study. Gynecol Oncol. 2010 Dec; 119(3):531-7. PMID: 20837359.
      Citations: 9     Fields:    Translation:Humans
    110. Zand B, Euscher ED, Soliman PT, Schmeler KM, Coleman RL, Frumovitz M, Jhingran A, Ramondetta LM, Ramirez PT. Rate of para-aortic lymph node micrometastasis in patients with locally advanced cervical cancer. Gynecol Oncol. 2010 Dec; 119(3):422-5. PMID: 20837355.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    111. Soliman PT, Frumovitz M, Spannuth W, Greer MJ, Sharma S, Schmeler KM, Ramirez PT, Levenback CF, Ramondetta LM. Lymphadenectomy during endometrial cancer staging: practice patterns among gynecologic oncologists. Gynecol Oncol. 2010 Nov; 119(2):291-4. PMID: 20708226.
      Citations: 30     Fields:    Translation:Humans
    112. Slomovitz BM, Lu KH, Johnston T, Coleman RL, Munsell M, Broaddus RR, Walker C, Ramondetta LM, Burke TW, Gershenson DM, Wolf J. A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinoma. Cancer. 2010 Dec 01; 116(23):5415-9. PMID: 20681032.
      Citations: 76     Fields:    Translation:HumansCTClinical Trials
    113. Monk BJ, Sill MW, McMeekin DS, Cohn DE, Ramondetta LM, Boardman CH, Benda J, Cella D. Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study. J Clin Oncol. 2009 Oct 01; 27(28):4649-55. PMID: 19720909.
      Citations: 175     Fields:    Translation:HumansCTClinical Trials
    114. Torres MA, Jhingran A, Thames HD, Levenback CF, Bodurka DC, Ramondetta LM, Eifel PJ. Concurrent chemoradiation in the routine management of patients with cervical cancer: does marital status matter? Int J Gynecol Cancer. 2009 Aug; 19(6):1107-12. PMID: 19820377.
      Citations: 2     Fields:    Translation:Humans
    115. Ramondetta LM, Johnson AJ, Sun CC, Atkinson N, Smith JA, Jung MS, Broaddus R, Iyer RB, Burke T. Phase 2 trial of mifepristone (RU-486) in advanced or recurrent endometrioid adenocarcinoma or low-grade endometrial stromal sarcoma. Cancer. 2009 May 01; 115(9):1867-74. PMID: 19241422.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    116. Coker AL, Eggleston KS, Du XL, Ramondetta L. Ethnic disparities in cervical cancer survival among Medicare eligible women in a multiethnic population. Int J Gynecol Cancer. 2009 Jan; 19(1):13-20. PMID: 19258935.
      Citations: 14     Fields:    Translation:Humans
    117. Basen-Engquist K, Scruggs S, Jhingran A, Bodurka DC, Lu K, Ramondetta L, Hughes D, Carmack Taylor C. Physical activity and obesity in endometrial cancer survivors: associations with pain, fatigue, and physical functioning. Am J Obstet Gynecol. 2009 Mar; 200(3):288.e1-8. PMID: 19110220.
      Citations: 35     Fields:    Translation:Humans
    118. Jones KL, Saucier JM, Sun CC, Bevers MW, Ramondetta LM, Brown J, Smith JA. Comparison of chemotherapy education and patient preferences in community versus academic gynecology oncology clinics. J Oncol Pharm Pract. 2008 Mar; 14(1):31-6. PMID: 18337438.
      Citations:    Fields:    Translation:Humans
    119. Westin SN, Bustillos D, Gano JB, Fields MM, Coker AL, Sun CC, Ramondetta LM. Social factors affecting treatment of cervical cancer: ethical issues and policy implications. Obstet Gynecol. 2008 Mar; 111(3):747-51. PMID: 18310380.
      Citations: 7     Fields:    Translation:Humans
    120. Navo MA, Smith JA, Gaikwad A, Burke T, Brown J, Ramondetta LM. In vitro evaluation of the growth inhibition and apoptosis effect of mifepristone (RU486) in human Ishikawa and HEC1A endometrial cancer cell lines. Cancer Chemother Pharmacol. 2008 Aug; 62(3):483-9. PMID: 18004570.
      Citations: 7     Fields:    Translation:HumansCells
    121. Ramondetta LM, Jhingran A. Eleven years: the long and winding road. Gynecol Oncol. 2007 Nov; 107(2):166-8. PMID: 17950382.
      Citations:    Fields:    Translation:Humans
    122. Torres MA, Jhingran A, Thames HD, Levenback CF, Bodurka DC, Ramondetta LM, Eifel PJ. Comparison of treatment tolerance and outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with standard treatment. Int J Radiat Oncol Biol Phys. 2008 Jan 01; 70(1):118-25. PMID: 17869451.
      Citations: 11     Fields:    Translation:Humans
    123. Smith JA, Gaikwad A, Yu J, Wolf JK, Brown J, Ramondetta LM, Stewart CF. In vitro evaluation of the effects of gefitinib on the modulation of cytotoxic activity of selected anticancer agents in a panel of human ovarian cancer cell lines. Cancer Chemother Pharmacol. 2008 Jun; 62(1):51-8. PMID: 17849119.
      Citations: 1     Fields:    Translation:HumansCells
    124. Slieper CF, Wasson K, Ramondetta LM. From technician to professional: integrating spirituality into medical practice. Am J Bioeth. 2007 Jul; 7(7):26-7. PMID: 17654378.
      Citations:    Fields:    Translation:Humans
    125. Lin YG, Deavers M, Sasan F, Zager JS, Ramondetta LM. Clinical challenges presented by three simultaneous solid tumors. Gynecol Oncol. 2006 Dec; 103(3):1159-63. PMID: 17055558.
      Citations:    Fields:    Translation:Humans
    126. Pothuri B, Ramondetta L, Eifel P, Deavers MT, Wilton A, Alektiar K, Barakat R, Soslow RA. Radiation-associated endometrial cancers are prognostically unfavorable tumors: a clinicopathologic comparison with 527 sporadic endometrial cancers. Gynecol Oncol. 2006 Dec; 103(3):948-51. PMID: 16870239.
      Citations: 8     Fields:    Translation:Humans
    127. Ramondetta LM, Sun C, Hollier L, Jarrett L, Folloder J, Tortolero-Luna G, Hughes A, Jhingran A, Brown J. Advanced cervical cancer treatment in Harris County: pilot evaluation of factors that prevent optimal therapy. Gynecol Oncol. 2006 Nov; 103(2):547-53. PMID: 16730784.
      Citations: 5     Fields:    Translation:Humans
    128. Smith JA, Gaikwad A, Ramondetta LM, Wolf JK, Brown J. Determination of the mechanism of gemcitabine modulation of cisplatin drug resistance in panel of human endometrial cancer cell lines. Gynecol Oncol. 2006 Nov; 103(2):518-22. PMID: 16690105.
      Citations: 5     Fields:    Translation:HumansCells
    129. Canada AL, Parker PA, Basen-Engquist K, de Moor JS, Ramondetta LM. Active coping mediates the association between religion/spirituality and functional well-being in ovarian cancer. Gynecol Oncol. 2005 Dec; 99(3 Suppl 1):S125. PMID: 16450431.
      Citations: 5     Fields:    Translation:Humans
    130. Canada AL, Parker PA, de Moor JS, Basen-Engquist K, Ramondetta LM, Cohen L. Active coping mediates the association between religion/spirituality and quality of life in ovarian cancer. Gynecol Oncol. 2006 Apr; 101(1):102-7. PMID: 16256181.
      Citations: 17     Fields:    Translation:Humans
    131. Lee CM, Slomovitz BM, Greer M, Sharma S, Gregurich MA, Burke T, Lu KH, Ramondetta LM. Practice patterns of SGO members for stage IIIA endometrial cancer. Gynecol Oncol. 2005 Jul; 98(1):77-83. PMID: 15907988.
      Citations: 6     Fields:    Translation:Humans
    132. Jenkins AD, Ramondetta LM, Sun C, Johnston T, Wolf JK, Bodurka DC, Brown J, Atkinson EN, Levenback C. Phase II trial of capecitabine in recurrent squamous cell carcinoma of the cervix. Gynecol Oncol. 2005 Jun; 97(3):840-4. PMID: 15882895.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    133. Orejuela FJ, Ramondetta LM, Smith J, Brown J, Lemos LB, Li Y, Hollier LM. Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium. Gynecol Oncol. 2005 May; 97(2):483-8. PMID: 15863148.
      Citations: 6     Fields:    Translation:Humans
    134. Slomovitz BM, Broaddus RR, Schmandt R, Wu W, Oh JC, Ramondetta LM, Burke TW, Gershenson DM, Lu KH. Expression of imatinib mesylate-targeted kinases in endometrial carcinoma. Gynecol Oncol. 2004 Oct; 95(1):32-6. PMID: 15385107.
      Citations: 8     Fields:    Translation:HumansCells
    135. Wolf JK, Bodurka DC, Gano JB, Deavers M, Ramondetta L, Ramirez PT, Levenback C, Gershenson DM. A phase I study of Adp53 (INGN 201; ADVEXIN) for patients with platinum- and paclitaxel-resistant epithelial ovarian cancer. Gynecol Oncol. 2004 Aug; 94(2):442-8. PMID: 15297186.
      Citations: 17     Fields:    Translation:HumansCellsCTClinical Trials
    136. Ramondetta LM, Tortolero-Luna G, Bodurka DC, Sills D, Basen-Engquist K, Gano J, Levenback C. Approaches for end-of-life care in the field of gynecologic oncology: an exploratory study. Int J Gynecol Cancer. 2004 Jul-Aug; 14(4):580-8. PMID: 15304150.
      Citations: 4     Fields:    Translation:Humans
    137. Amant F, Vergote I. Importance of the endometrioid carcinoma subtype and sarcomatous component in uterine carcinosarcoma. Gynecol Oncol. 2004 Apr; 93(1):272-3; author reply 273-4. PMID: 15047252.
      Citations:    Fields:    Translation:Humans
    138. Smith JA, Brown J, Martin MC, Ramondetta LM, Wolf JK. An in vitro study of the inhibitory activity of gemcitabine and platinum agents in human endometrial carcinoma cell lines. Gynecol Oncol. 2004 Jan; 92(1):314-9. PMID: 14751176.
      Citations: 9     Fields:    Translation:HumansCells
    139. Ramondetta LM, Sills D. Spirituality and religion in the "art of dying". J Clin Oncol. 2003 Dec 01; 21(23):4460-2. PMID: 14645439.
      Citations:    Fields:    Translation:Humans
    140. Shvartsman HS, Langstein H, Worley C, Malpica A, Ramondetta LM. Use of a vacuum-assisted closure device in the treatment of recurrent Paget's disease of the vulva. Obstet Gynecol. 2003 Nov; 102(5 Pt 2):1163-6. PMID: 14607043.
      Citations: 2     Fields:    Translation:Humans
    141. Pothuri B, Ramondetta L, Martino M, Alektiar K, Eifel PJ, Deavers MT, Venkatraman E, Soslow RA, Barakat RR. Development of endometrial cancer after radiation treatment for cervical carcinoma. Obstet Gynecol. 2003 May; 101(5 Pt 1):941-5. PMID: 12738155.
      Citations: 3     Fields:    Translation:Humans
    142. Holtz D, Ramondetta LM, Burke TW, Palazzo JP, Dunton CJ, Atkinson EN, Broaddus RR. PTEN expression in tamoxifen-associated endometrial cancers. Anticancer Res. 2002 Sep-Oct; 22(5):2945-8. PMID: 12530022.
      Citations: 2     Fields:    Translation:Humans
    143. Ramirez PT, Gershenson DM, Tortolero-Luna G, Ramondetta LM, Fightmaster D, Wharton JT, Wolf JK. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53. Gynecol Oncol. 2001 Dec; 83(3):543-8. PMID: 11733969.
      Citations: 6     Fields:    Translation:HumansCells
    144. Ramondetta L, Burke TW, Levenback C, Bevers M, Bodurka-Bevers D, Gershenson DM. Treatment of uterine papillary serous carcinoma with paclitaxel. Gynecol Oncol. 2001 Jul; 82(1):156-61. PMID: 11426978.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    145. Gordinier ME, Ramondetta LM, Parker LP, Wolf JK, Follen M, Gershenson DM, Bodurka-Bevers D. Survey of female gynecologic oncologists and fellows: balancing professional and personal life. Gynecol Oncol. 2000 Nov; 79(2):309-14. PMID: 11063663.
      Citations: 6     Fields:    Translation:Humans
    146. Ramondetta LM, Sherwood JB, Dunton CJ, Palazzo JP. Endometrial cancer in polyps associated with tamoxifen use. Am J Obstet Gynecol. 1999 Feb; 180(2 Pt 1):340-1. PMID: 9988797.
      Citations: 5     Fields:    Translation:Humans
    147. Ramondetta LM, Carlson JA, Schwarting R. Atypical Meigs' syndrome and bilateral ovarian stromal hyperplasia. A case report. J Reprod Med. 1997 Sep; 42(9):603-5. PMID: 9336761.
      Citations:    Fields:    Translation:HumansCells
    148. van Hoeven KH, Ramondetta L, Kovatich AJ, Bibbo M, Dunton CJ. Quantitative image analysis of MIB-1 reactivity in inflammatory, hyperplastic, and neoplastic endocervical lesions. Int J Gynecol Pathol. 1997 Jan; 16(1):15-21. PMID: 8986527.
      Citations: 2     Fields:    Translation:Humans
    149. Ramondetta LM, Dunton CJ, Shapiro MJ, Carlson JA, Arsuaga J. Percutaneous abscess drainage in gynecologic cancer patients. Gynecol Oncol. 1996 Sep; 62(3):366-9. PMID: 8812534.
      Citations: 1     Fields:    Translation:Humans
    150. Clinical report - Maternal-fetal intervention and fetal care centers. Pediatrics. 128.
    151. Prospective evaluation of the molecular effects of metformin on the endometrium in women with newly diagnosed endometrial cancer. Gynecologic Oncology. 143:466-471.
    152. Controversies in Endometrial Cancer Screening and Diagnosis. 241-247.
    153. Room for improvement. Gynecologic Oncology. 142:525-530.
    154. Dying well. Gynecologic Oncology.
    155. Node-positive adenocarcinoma of the endometrium. Obstetrical and Gynecological Survey. 64:798-800.
    156. Association between Vaginal Douching and Genital Human Papillomavirus Infection among Women in the United States. Journal of Infectious Diseases. 214:1370-1375.
    157. Improved survival with bevacizumab in advanced cervical cancer. Obstetrical and Gynecological Survey. 69:331-332.
    158. End-of-life care for elderly patients with gynecologic cancer. 367-390.
    159. Survival of patients with metastatic leiomyosarcoma. Cancer Medicine. 5:3437-3444.
    160. Human Papillomavirus Vaccine Uptake in Texas Pediatric Care Settings. Journal of Community Health. 1-8.
    161. Improved survival with bevacizumab in advanced cervical cancer. New England Journal of Medicine. 370:734-743.
    162. Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancer. Cancer. 121:3444-3451.
    163. A pilot study of laparoscopic extraperitoneal lymph node dissection in patients with locally advanced cervical cancer. Clinical Ovarian Cancer. 3:113-117.
    164. In reply. Obstetrics and Gynecology. 118:710-711.
    RAMONDETTA's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (508)
    Explore
    _
    Co-Authors (95)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _